Cycloplegic effect of atropine compared with cyclopentolate-tropicamide combination in children with hypermetropia

Rabi Yahaya Sani1, Sadiq Hassan1, Saudat Garba Habib1

  • 1Department of Ophthalmology, Faculty of Clinical Sciences, College of Health Sciences, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria.

Insights

A combination of cyclopentolate and tropicamide offers a viable alternative to atropine for cycloplegic refraction in children with hypermetropia, providing similar results with potentially fewer side effects.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Optometry

Background:

  • Cycloplegic refraction is crucial for diagnosing hypermetropia in children.
  • Atropine, while effective, has a prolonged action and significant side effects.
  • Shorter-acting cycloplegic agents are preferred for pediatric use.

Purpose of the Study:

  • To compare the efficacy of atropine 1% with a combination of cyclopentolate 1% and tropicamide 1% for cycloplegic refraction.
  • To evaluate the cycloplegic effect of these agents in children diagnosed with hypermetropia.

Main Methods:

  • A crossover interventional study was conducted on 63 children (126 eyes) aged 5-12 years with hypermetropia.
  • Two cycloplegic refraction regimens were administered: atropine 1% and cyclopentolate 1% with tropicamide 1%.
  • Data were analyzed using SPSS v22.0, with P ≤ 0.05 considered significant.

Main Results:

  • No statistically significant difference was found in the mean spherical equivalent values between atropine 1% and the cyclopentolate/tropicamide combination for both right (P=0.59) and left eyes (P=0.56).
  • Mean spherical equivalent for the right eye was 4.73 ± 2.1 DS (atropine) vs. 4.54 ± 1.9 DS (combination).
  • Mean spherical equivalent for the left eye was 4.74 ± 2.0 DS (atropine) vs. 4.54 ± 1.8 DS (combination).

Conclusions:

  • The combination of 1% cyclopentolate and 1% tropicamide is an effective alternative to 1% atropine for cycloplegic refraction in pediatric hypermetropia.
  • This combination may offer a more favorable side effect profile compared to atropine.
  • Further research could explore long-term outcomes and patient tolerance.
Abstract

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
173
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.9K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.5K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
2.0K